- [Not loaded yet]
- That is false. Hundreds of trials were suspended bc of the COVID-19 pandemic, but trials were not terminated en masse due to changes in "agency priorities" — that happened for the first time under the Trump administration and Bhattacharya's watch.
- Baldwin quotes directly from my article abt advisory-council vacancies. BALDWIN: This poses a very serious threat to NIH's ability to fund research. BHATTACHARYA: I've ordered the ICs to nominate new members... including for the advisory committee to the director [which hasn't met since Dec 2024]
Feb 3, 2026 16:01
- An NIH staff member texted me immediately: "His answer was bullshit btw. It implied that the fault was in NIH not nominating people quick enough rather than the administration not doing their part" to review the slates that agency staff had already submitted.
- JIM BANKS (R-Indiana): Massachusetts, which is virtually the same size as my state (?!), received nearly $3 billion last year. Can you explain why schools on the coast seem to get more NIH funding than schools like my state, which is doing a lot of research as well?
